InsidersTradesSigma
Track the 名臣健康 stock price and the full management transaction log of the company, a listed equity based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 名臣健康 has published 2 public disclosures. Market capitalisation: €4.3bn. The latest transaction was filed on 17 July 2023 (Sale). Among the most active insiders: 彭小青. Every trade is accessible without an account.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€2m
2 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,464 of 29,064 companies
38.1
score / 100
Value25
Quality51
FCF yld0.0%
Earn yld0.7%
EV/EBITDA55.7x
ROE2.8%
Gross mgn54%
Net mgn1.9%
Debt/EBITDA1.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 July 2023
Acerca de 名臣健康
名臣健康 es una empresa especializada en el sector de la salud y farmacéutico. Cotiza en el mercado XSHE.